tirzepatide and menopause New study links combination of hormone therapy to greater weight loss after Menopause Hormone Therapy May Boost

The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) is the landmark efficacy data: tirzepatide at 15mg weekly produced 22.5% average body weight reduction over 72 weeks in adults with obesity without diabetes the highest weight reduction ever documented in a pharmaceutical trial

Recently, it was shown that cysteine uptake via excitatory amino acid carrier 1 suppresses ischemia-induced neuronal death through promotion of hippocampal GSH synthesis in ischemic animal models (162)

Add collagen powder to your morning protein shake for an easy, flavorless boost

Taken as a lozenge, zinc can shorten the duration of a cold

Members access personalized protocol builders, detailed titration schedules, and expert support that goes far beyond what any single chart can provide